Johannes Fruehauf MD, PhD is a physician-scientist and life-science entrepreneur. He is the Founder and CEO of Biolabs and the Cofounder and Executive Chairman of LabCentral, the national network for biotech incubators and the largest co-working spaces for life-science startup companies. Together, Biolabs/LabCentral have helped launch over 850 venture funded startup companies in the life sciences in 17 different cities with a presence in the US, Germany, France and Japan. The concept of these facilities is built around openness, transparency and shared resources and has changed the way biotech companies are built around the world. Companies launched at BioLabs/LabCentral have raised over $30bn while in residence since 2010. LabCentral and BioLabs were also the recipient of the prestigious Prix Galien Award in 2022 for the best biotech startup launchpads in the “Incubators, Accelerators and Equity” category. Dr. Fruehauf is also a Founding General Partner at Mission BioCapital, an early-stage venture capital fund providing capital to start-up companies in the life sciences. Dr. Fruehauf studied Medicine in Germany and France. He practiced medicine (internal medicine and OB/Gyn) for several years in Germany before coming to Boston for a post-doc at Beth Israel Deaconess Medical Center/Harvard Medical School. He is an author of 30 peer reviewed articles in the medical literature and inventor on numerous issued and pending patents.